Profil
Mark W.
Schwartz is currently the Chairman of MWS Strategic Advisors LLC, Director of Biotechnology Innovation Organization, Director of NeoLight LLC, and Independent Director of SquareX Pharmaceuticals Corp.
He was previously the President & CEO of Bayhill Therapeutics, President, CEO & Director of Galena Biopharma, President & CEO of Apthera, President & CEO of Calyx Therapeutics, Managing Director-Life Sciences of Arizona Science & Technology Enterprises LLC, Executive Director of Targazyme, and Chief Commercial Officer of Trega Biosciences.
He also served as the COO & Executive VP of Phio Pharmaceuticals Corp.
Schwartz holds a doctorate from Arizona State University and an undergraduate degree from Grinnell College.
Postes actifs de Mark W. Schwartz
| Sociétés | Poste | Début |
|---|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that develops pharmaceuticals for cold sores | Directeur/Membre du Conseil | 01/11/2022 |
MWS Strategic Advisors LLC
MWS Strategic Advisors LLC Investment ManagersFinance MWS Strategic Advisors LLC is a company that specializes in the conceptual development and production of animated films. The company focuses on producing high-quality films within budget and on time. The company has experience working on various production specifications, from feature-length theatrical films to 30-second commercials. The company has successfully co-produced projects within the European Union community and has a production capacity of approximately seventy-five half-hour episodes per year. The company is based in Discovery Bay, CA. | Président | - |
NeoLight LLC
NeoLight LLC Medical SpecialtiesHealth Technology Designs and manufactures retinal imaging systems that treat infants | Directeur/Membre du Conseil | - |
Anciens postes connus de Mark W. Schwartz
| Sociétés | Poste | Fin |
|---|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products through biopharmaceutical research and development | Directeur Général | 31/01/2017 |
Arizona Science & Technology Enterprises LLC | Corporate Officer/Principal | 01/01/2004 |
Calyx Therapeutics, Inc.
Calyx Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides therapies services for diabetes and inflammatory diseases | President | 01/01/2003 |
Trega Biosciences, Inc.
Trega Biosciences, Inc. BiotechnologyHealth Technology Provides identification and early stage development of novel and small moelcule drug therapies | Corporate Officer/Principal | 01/01/2001 |
Targazyme, Inc.
Targazyme, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals to improve clinical efficacy and safety in stem cell transplantation, immunotherapy for cancer, regenerative medicine and gene therapy | Directeur/Membre du Conseil | - |
Formation de Mark W. Schwartz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Trega Biosciences, Inc.
Trega Biosciences, Inc. BiotechnologyHealth Technology Provides identification and early stage development of novel and small moelcule drug therapies | Health Technology |
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products through biopharmaceutical research and development | Health Technology |
Arizona State University
Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Grinnell College
Grinnell College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apthera, Inc.
Apthera, Inc. Medical/Nursing ServicesHealth Services Develops a pipeline of peptide-based immunotherapies for cancers | Health Services |
Arizona Science & Technology Enterprises LLC | |
Calyx Therapeutics, Inc.
Calyx Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides therapies services for diabetes and inflammatory diseases | Health Services |
Targazyme, Inc.
Targazyme, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals to improve clinical efficacy and safety in stem cell transplantation, immunotherapy for cancer, regenerative medicine and gene therapy | Health Technology |
Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. BiotechnologyHealth Technology Develops RNAi-based medical technologies and therapies | Health Technology |
NeoLight LLC
NeoLight LLC Medical SpecialtiesHealth Technology Designs and manufactures retinal imaging systems that treat infants | Health Technology |
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that develops pharmaceuticals for cold sores | Health Technology |
MWS Strategic Advisors LLC
MWS Strategic Advisors LLC Investment ManagersFinance MWS Strategic Advisors LLC is a company that specializes in the conceptual development and production of animated films. The company focuses on producing high-quality films within budget and on time. The company has experience working on various production specifications, from feature-length theatrical films to 30-second commercials. The company has successfully co-produced projects within the European Union community and has a production capacity of approximately seventy-five half-hour episodes per year. The company is based in Discovery Bay, CA. | Finance |
















